|
[1]VILSTRUP H,AMODIO P,BAJAJ J,et al.Hepatic encephalopathy in chronic liver disease:2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver[J].Hepatology,2014,60(2):715-735.
|
|
[2]Chinese Society of Gastroenterology and Chinese Society of Hepatology,Chinese Medical Association.Comem on thediagnosis andtreatment of hepatic encephalopathy in China(Chongqing,2013)[J].Chin J Hepatol,2013,21(9):641-651.(in Chinese)中华医学会消化病学分会,中华医学会肝病学分会.中国肝性脑病诊治共识意见(2013年,重庆)[J].中华肝脏病杂志,2013,21(9):641-651.
|
|
[3]HOU Y.The clinical comparison of cirrhosis patients with different etiological upper digestive tract hemorrhage[J].J Clin Exp Med,2015,14(12):999-1001.(in Chinese)侯昀.肝硬化不同病因上消化道出血患者的临床对比[J].临床和实验医学杂志,2015,14(12):999-1001.
|
|
[4]CABRAL CM,BURNS DL.Low-protein diets for hepatic encephalopathy debunked:let them eat steak[J].Nutr Clin Pract,2011,26(2):155-159.
|
|
[5]AMODIO P,BEMEUR C,BUTTERWORTH R,et al.The nutritional management of hepatic encephalopathy in patients with cirrhosis:International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus[J].Hepatology,2013,58(1):325-336.
|
|
[6]PERES WA,LENTO DF,BALUZ K,et al.Phase angle as a nutritionalevaluation tool in all stages of chronic liver disease[J].Nutr Hosp,2012,27(6):2072-2078.
|
|
[7]PLAUTH M,CABRE E,RIGGIO O,et al.ESPEN guidelines on enteral nutrition:liver disease[J].Clin Nutr,2006,25(2):285-294.
|
|
[8]TSIEN CD,McC ULLOUGH AJ,DASARATHY S.Late evening snack:exploiting a period of anabolic opportunity in cirrhosis[J].J Gastroenterol Hepatol,2012,27(3):430-441.
|
|
[9]Chinese Society of Critical Care Medicine,Chinese Medical Association.Guidelines on nutritional support for critically ill patients[J].Chin Critical Care Med,2006,18(10):582-590.(in Chinese)中华医学会重症医学分会.危重患者营养支持指导意见[J].中国危重病急救医学,2006,18(10):582-590.
|
|
[10]CORDOBA J,LOPEZ-HELLIN J,PLANAS M,et al.Normal protein diet for episodic hepatic encephalopathy:results of a randomized study[J].Hepatol,2004,41(1):38-43.
|
|
[11]SIMN-TALERO M,GARCA-MARTNEZ R,TORRENS M,et al.Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy:a randomized double-blind study[J].J Hepatol,2013,59(6):1184-1192.
|
|
[12]LES I,DOVAL E,GARCIA-MARTINEZ R,et al.Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy:a randomized study[J].Am J Gastroenterol,2011,106(6):1081-1088.
|
|
[13]GLUUD LL,DAM G,BORRE M,et al.Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials[J].J Nutr,2013,143(8):1263-1268.
|
|
[14]KAWAGUCHI T,SHIRAISHI K,ITO T,et al.Branched-chain amino acids prevent hepatocarcinogenesis and prolong survival of patients with cirrhosis[J].Clin Gastroenterol Hepatol,2014,12(6):1012-1018.
|
|
[15]LEISE MD,POTERUCHA JJ,KAMATH PS,et al.Management of hepatic encephalopathy in the hospital[J].Mayo Clin Proc,2014,89(2):241-253.
|
|
[16]SHARMA P,SHARMA BC,AGRAWAL A,et al.Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis:an open labeled randomized controlled trial of lactulose versus no lactulose[J].J Gastroenterol Hepatol,2012,27(8):1329-1335.
|
|
[17]JAIN L,SHARMA BC,SRIVASTAVA S,et al.Serum endotoxin,inflammatory mediators,and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy[J].J Gastroenterol Hepatol,2013,28(7):1187-1193.
|
|
[18]SHARMA BC,SHARMA P,LUNIA MK,et al.A randomized,double-blind,controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy[J].Am J Gastroenterol,2013,108(9):1458-1463.
|
|
[19]BAJAJ JS,RIDLON JM,HYLEMON PB,et al.Linkage of gut microbiome with cognition in hepatic encephalopathy[J].Am J Physiol Gastrointest Liver Physiol,2012,302(1):g168-g175.
|
|
[20]LUNIA MK,SHARMA BC,SHARMA P,et al.Probiotics prevent hepatic encephalopathy in patients with cirrhosis:a randomized controlled trial[J].Clin Gastroenterol Hepatol,2014,12(6):1003-1008.
|
|
[21]AGRAWAL A,SHARMA BC,SHARMA P,et al.Secondary prophylaxis of hepatic encephalopathy in cirrhosis:an open-label,randomized controlled trial of lactulose,probiotics,and no therapy[J].Am J Gastroenterol,2012,107(7):1043-1050.
|
|
[22]QURESHI MO,KHOKHAR N,SALEEM A,et al.Correlation of hyponatremia with hepatic encephalopathy and severity of liver disease[J].J Coll Physicians Surg Pak,2014,24(2):135-137.
|
|
[23]LIU HL.Relationship between hyponatremia and main complications in patients with decompensated cirrhosis[J].J Clin Exp Med,2015,14(17):1448-1450.(in Chinese)刘红凌.肝硬化失代偿期患者低钠血症与其他并发症相关性研究[J].临床和实验医学杂志,2015,14(17):1448-1450.
|
|
[24]LOPES PJ,MEI MF,GUARDIA AC,et al.Correlation between serum magnesium levels and hepatic encephalopathy in immediate post liver transplantation period[J].Transplant Proc,2013,45(3):1122-1125.
|
|
[25]CHAVEZ-TAPIA NC,CESAR-ARCE A,BARRIENTOS-GUTIERREZ T,et al.A systematic review and meta-analysis of the use of oral zinc in the treatment of hepatic encephalopathy[J].Nutr J,2013,12:74.
|
|
[26]RIVERA-MANCIA S,RIOS C,MONTES S.Manganese accumulation in the CNS and associated pathologies[J].Biometals,2011,24(5):811-825.
|
DownLoad: